SCHEMBL8414792

SCHEMBL8414792

Cc1cc(NS(=O)(=O)c2cc[c]cc2)cc(Br)n1

nearest known ligand 0.51

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 3/20 0.51
GAA P10253 1/20 0.48
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 1/20 0.46
TSHR P16473 3/20 0.43
PDE4A P27815 1/20 0.42
AGO2 Q9UKV8 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
CYP3A4 P08684 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HSD11B1 P28845 1/20 0.40
CYTH2 Q99418 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8413157 0.90 HTR6 (0.57) HTR6GAAALDH1A1LMNASMN1; SMN2
SCHEMBL7823751 0.83 HTR6 (0.74) HTR6GAAALDH1A1KDM4ELMNA
SCHEMBL7836239 0.79 PKM (0.60) GAAALDH1A1KDM4ELMNATSHR
SCHEMBL4515051 0.77 TSHR (0.71) GAAALDH1A1KDM4ELMNATSHR
SCHEMBL11757838 0.77 PDE4A (0.69) ALDH1A1KDM4ELMNAPDE4AAGO2
SCHEMBL8413230 0.74 CES1 (0.44) HTR6GAAALDH1A1LMNASMN1; SMN2
SCHEMBL17682474 0.73 TSHR (0.70) GAAALDH1A1KDM4ELMNATSHR
SCHEMBL17593130 0.72 TSHR (0.76) GAAALDH1A1KDM4ELMNATSHR
SCHEMBL482662 0.72 CA12 (0.62) GAAALDH1A1LMNASMN1; SMN2TDP1
SCHEMBL7824815 0.71 CES1 (0.62) HTR6GAAALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed